Single Dose of Ivermectin is not Useful in Patients with Hematological Disorders and COVID-19 Illness: A Phase II B Open Labelled Randomized Controlled Trial
George et al., Indian Journal of Hematology and Blood Transfusion, doi:10.1007/s12288-022-01546-w
https://c19ivm.org/george.html